Cel-Sci (CVM) vs Evaxion A/S (EVAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Evaxion A/S (EVAX) has outperformed Cel-Sci (CVM) over the past year, losing 44.8% versus a loss of 79.1%. Over five years, EVAX leads with a -99.2% price change compared with -99.3% for CVM. Cel-Sci is the larger company by market cap ($35.3 million vs $27.5 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVM | EVAX |
|---|---|---|
| Share price | $2.01 | $3.05 |
| Market cap | $35.30M | $27.52M |
| 1-day change | -5.79% | -2.87% |
| YTD return | -59.51% | -33.75% |
| 1-year return | -79.12% | -44.76% |
| 5-year return | -99.32% | -99.20% |
| EPS (TTM) | $-1.69 | $-1.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.39 | $12.15 |
| 52-week low | $0.89 | $2.77 |
| Distance from 52-week high | -80.68% | -74.90% |
| Average volume | 241.50K | 199.49K |
| Shares outstanding | 17.59M | 9.02M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EVAX has outperformed CVM by 34.4 percentage points over the past year.
CVM vs EVAX FAQ
Which is bigger, Cel-Sci or Evaxion A/S?
Cel-Sci (CVM) is larger, with a market capitalization of $35.30M compared with $27.52M for Evaxion A/S (EVAX).
Which stock has performed better over the past year, CVM or EVAX?
EVAX returned -44.76% over the past 12 months, compared with -79.12% for CVM (price return, excluding dividends). Past performance does not predict future results.
Are Cel-Sci and Evaxion A/S in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.